Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Teva
Citi
Chinese Patent Office
Mallinckrodt
McKesson
McKinsey
Cerilliant

Generated: July 21, 2018

DrugPatentWatch Database Preview

Dapiprazole hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for dapiprazole hydrochloride and what is the scope of dapiprazole hydrochloride patent protection?

Dapiprazole hydrochloride
is the generic ingredient in one branded drug marketed by Fera Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for dapiprazole hydrochloride.
Summary for dapiprazole hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Bulk Api Vendors: 39
Patent Applications: 8
DailyMed Link:dapiprazole hydrochloride at DailyMed
Synonyms for dapiprazole hydrochloride
3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride
3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride
3-[2-[4-(o-tolyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride
5,6,7,8-Tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-1,2,4-Triazolo[4,3-a]pyridine Hydrochloride
72822-13-0
822D130
A837632
AC-8851
AC1OCENK
AF 2139
AF-2139
AKOS015966533
AN-7595
AOB6054
API0002214
AS-16932
BC677609
C-23865
CAS-72822-13-0
CHEMBL1201044
CS-5720
D03648
Dapiprazole (hydrochloride)
Dapiprazole HCl
Dapiprazole hydrochloride (USAN)
Dapiprazole hydrochloride [USAN]
Dapiprazole hydrochloride, >=98% (HPLC)
DS9UJN1I0X
DSSTox_CID_28595
DSSTox_GSID_48669
DSSTox_RID_82866
DTXSID7048669
FT-0665471
HY-A0142A
MolPort-020-000-752
NCGC00262927-01
Rev-Eyes
Rev-Eyes (TN)
SCHEMBL667604
Tox21_113035
Tox21_113035_1
UNII-DS9UJN1I0X

US Patents and Regulatory Information for dapiprazole hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fera Pharms DAPIPRAZOLE HYDROCHLORIDE dapiprazole hydrochloride SOLUTION/DROPS;OPHTHALMIC 019849-001 Dec 31, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Colorcon
Farmers Insurance
McKesson
Cantor Fitzgerald
Accenture
Harvard Business School
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.